Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

All we have to go on is the fact that unlike so many manufacturers of Concerta(sister ADHD drug) & Focalin, IPCI doesn't struggle whatsoever manufacturing effective "hard to manufacture generics" and despite losing 180 days exclusivity 2 years ago now on their only 2 approved strengths of FocalinXR they're still driving over +$4M in revenues...so the tale of the rest of their FocalinXR revenues and ANDA's is still far from being told IMO Mike...but for the time being I'm just gonna let their ANDA pipeline play out knowing full well major Rexista catalysts are en route within these next 3 months and 1 year from today with FDA Rexista approval in hand people will be looking back on these final under the radar days either smiling because they loaded their proverbial boats or doing the coulda woulda shoulda cheers amigo!